The University of Chicago Header Logo

Connection

Elliot Gershon to Middle Aged

This is a "connection" page, showing publications Elliot Gershon has written about Middle Aged.
Connection Strength

0.436
  1. NRXN1 is associated with enlargement of the temporal horns of the lateral ventricles in psychosis. Transl Psychiatry. 2019 09 17; 9(1):230.
    View in: PubMed
    Score: 0.047
  2. Neural Processing of Repeated Emotional Scenes in Schizophrenia, Schizoaffective Disorder, and Bipolar Disorder. Schizophr Bull. 2021 08 21; 47(5):1473-1481.
    View in: PubMed
    Score: 0.013
  3. Biomarker Profiles in Psychosis Risk Groups Within Unaffected Relatives Based on Familiality and Age. Schizophr Bull. 2021 07 08; 47(4):1058-1067.
    View in: PubMed
    Score: 0.013
  4. Regression dynamic causal modeling for resting-state fMRI. Hum Brain Mapp. 2021 05; 42(7):2159-2180.
    View in: PubMed
    Score: 0.013
  5. Brain gray matter network organization in psychotic disorders. Neuropsychopharmacology. 2020 03; 45(4):666-674.
    View in: PubMed
    Score: 0.012
  6. Smooth pursuit eye movement deficits as a biomarker for psychotic features in bipolar disorder-Findings from the PARDIP study. Bipolar Disord. 2020 09; 22(6):602-611.
    View in: PubMed
    Score: 0.012
  7. Electrophysiological correlates of emotional scene processing in bipolar disorder. J Psychiatr Res. 2020 01; 120:83-90.
    View in: PubMed
    Score: 0.012
  8. Characterizing functional regional homogeneity (ReHo) as a B-SNIP psychosis biomarker using traditional and machine learning approaches. Schizophr Res. 2020 01; 215:430-438.
    View in: PubMed
    Score: 0.012
  9. Auditory steady-state EEG response across the schizo-bipolar spectrum. Schizophr Res. 2019 07; 209:218-226.
    View in: PubMed
    Score: 0.011
  10. Shared Genetic Risk of Schizophrenia and Gray Matter Reduction in 6p22.1. Schizophr Bull. 2019 01 01; 45(1):222-232.
    View in: PubMed
    Score: 0.011
  11. Efficient region-based test strategy uncovers genetic risk factors for functional outcome in bipolar disorder. Eur Neuropsychopharmacol. 2019 01; 29(1):156-170.
    View in: PubMed
    Score: 0.011
  12. Alterations in intrinsic fronto-thalamo-parietal connectivity are associated with cognitive control deficits in psychotic disorders. Hum Brain Mapp. 2019 01; 40(1):163-174.
    View in: PubMed
    Score: 0.011
  13. Polygenic risk for schizophrenia and measured domains of cognition in individuals with psychosis and controls. Transl Psychiatry. 2018 04 12; 8(1):78.
    View in: PubMed
    Score: 0.011
  14. Genome-wide association study of borderline personality disorder reveals genetic overlap with bipolar disorder, major depression and schizophrenia. Transl Psychiatry. 2017 06 20; 7(6):e1155.
    View in: PubMed
    Score: 0.010
  15. Impaired Context Processing is Attributable to Global Neuropsychological Impairment in Schizophrenia and Psychotic Bipolar Disorder. Schizophr Bull. 2017 03 01; 43(2):397-406.
    View in: PubMed
    Score: 0.010
  16. The Pharmacogenomics of Bipolar Disorder study (PGBD): identification of genes for lithium response in a prospective sample. BMC Psychiatry. 2016 May 05; 16:129.
    View in: PubMed
    Score: 0.009
  17. Polygenic risk for type 2 diabetes mellitus among individuals with psychosis and their relatives. J Psychiatr Res. 2016 Jun; 77:52-8.
    View in: PubMed
    Score: 0.009
  18. Pursuit eye movements as an intermediate phenotype across psychotic disorders: Evidence from the B-SNIP study. Schizophr Res. 2015 Dec; 169(1-3):326-333.
    View in: PubMed
    Score: 0.009
  19. Behavioral response inhibition in psychotic disorders: diagnostic specificity, familiality and relation to generalized cognitive deficit. Schizophr Res. 2014 Nov; 159(2-3):491-8.
    View in: PubMed
    Score: 0.008
  20. Regressing to Prior Response Preference After Set Switching Implicates Striatal Dysfunction Across Psychotic Disorders: Findings From the B-SNIP Study. Schizophr Bull. 2015 Jul; 41(4):940-50.
    View in: PubMed
    Score: 0.008
  21. Emotion recognition deficits in schizophrenia-spectrum disorders and psychotic bipolar disorder: Findings from the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) study. Schizophr Res. 2014 Sep; 158(1-3):105-12.
    View in: PubMed
    Score: 0.008
  22. Reduced levels of vasopressin and reduced behavioral modulation of oxytocin in psychotic disorders. Schizophr Bull. 2014 Nov; 40(6):1374-84.
    View in: PubMed
    Score: 0.008
  23. Neuropsychological impairments in schizophrenia and psychotic bipolar disorder: findings from the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) study. Am J Psychiatry. 2013 Nov; 170(11):1275-84.
    View in: PubMed
    Score: 0.008
  24. Elevated antisaccade error rate as an intermediate phenotype for psychosis across diagnostic categories. Schizophr Bull. 2014 Sep; 40(5):1011-21.
    View in: PubMed
    Score: 0.008
  25. Linkage of Alzheimer's disease to chromosome 21 and chromosome 19 markers: effect of age of onset assumptions. Genet Epidemiol. 1993; 10(6):449-54.
    View in: PubMed
    Score: 0.007
  26. Neurophysiological evidence of corollary discharge function during vocalization in psychotic patients and their nonpsychotic first-degree relatives. Schizophr Bull. 2013 Nov; 39(6):1272-80.
    View in: PubMed
    Score: 0.007
  27. Two gene co-expression modules differentiate psychotics and controls. Mol Psychiatry. 2013 Dec; 18(12):1308-14.
    View in: PubMed
    Score: 0.007
  28. Genome-wide significant association between a 'negative mood delusions' dimension in bipolar disorder and genetic variation on chromosome 3q26.1. Transl Psychiatry. 2012 Sep 25; 2:e165.
    View in: PubMed
    Score: 0.007
  29. Case-control association study of TGOLN2 in attempted suicide. Am J Med Genet B Neuropsychiatr Genet. 2010 Jul; 153B(5):1016-23.
    View in: PubMed
    Score: 0.006
  30. Genetic control of individual differences in gene-specific methylation in human brain. Am J Hum Genet. 2010 Mar 12; 86(3):411-9.
    View in: PubMed
    Score: 0.006
  31. Genome-wide association study of bipolar disorder in European American and African American individuals. Mol Psychiatry. 2009 Aug; 14(8):755-63.
    View in: PubMed
    Score: 0.006
  32. Measuring cholinergic sensitivity: I. Arecoline effects in bipolar patients. Biol Psychiatry. 1989 Mar 01; 25(5):610-7.
    View in: PubMed
    Score: 0.006
  33. Cytogenetic studies of males with schizophrenia. Screening for the fragile X chromosome and other chromosomal abnormalities. Schizophr Res. 1988 Jul-Aug; 1(4):277-81.
    View in: PubMed
    Score: 0.005
  34. Familial aggregation of postpartum mood symptoms in bipolar disorder pedigrees. Bipolar Disord. 2008 Feb; 10(1):38-44.
    View in: PubMed
    Score: 0.005
  35. Clinical features of illness in siblings with schizophrenia or schizoaffective disorder. Arch Gen Psychiatry. 1987 Oct; 44(10):891-6.
    View in: PubMed
    Score: 0.005
  36. Birth-cohort changes in manic and depressive disorders in relatives of bipolar and schizoaffective patients. Arch Gen Psychiatry. 1987 Apr; 44(4):314-9.
    View in: PubMed
    Score: 0.005
  37. Mood-incongruent psychotic features in bipolar disorder: familial aggregation and suggestive linkage to 2p11-q14 and 13q21-33. Am J Psychiatry. 2007 Feb; 164(2):236-47.
    View in: PubMed
    Score: 0.005
  38. Neuropeptide gene polymorphisms in affective disorder and schizophrenia. J Psychiatr Res. 1987; 21(4):581-7.
    View in: PubMed
    Score: 0.005
  39. Epstein-Barr virus and depression. Arch Gen Psychiatry. 1986 Aug; 43(8):815-6.
    View in: PubMed
    Score: 0.005
  40. Pirbuterol trial as antidepressant. Biol Psychiatry. 1986 May; 21(5-6):565-6.
    View in: PubMed
    Score: 0.005
  41. Neuropeptides in human cerebrospinal fluid. Life Sci. 1985 Sep 30; 37(13):1265-70.
    View in: PubMed
    Score: 0.004
  42. Muscarinic cholinergic receptors on skin fibroblasts in familial affective disorder. N Engl J Med. 1984 Jul 26; 311(4):225-30.
    View in: PubMed
    Score: 0.004
  43. A family study of schizoaffective, bipolar I, bipolar II, unipolar, and normal control probands. Arch Gen Psychiatry. 1982 Oct; 39(10):1157-67.
    View in: PubMed
    Score: 0.004
  44. An effective method for measuring salivary lithium in patients on anticholinergic drugs. Biol Psychiatry. 1982 Oct; 17(10):1145-55.
    View in: PubMed
    Score: 0.004
  45. Red cell ouabain-sensitive Na+-K+-adenosine triphosphatase: a state marker in affective disorder inversely related to plasma cortisol. Biol Psychiatry. 1982 Sep; 17(9):981-92.
    View in: PubMed
    Score: 0.004
  46. A new method for the use of salivary lithium concentrations as an indicator of plasma lithium levels. Biol Psychiatry. 1982 Jan; 17(1):99-102.
    View in: PubMed
    Score: 0.003
  47. Patient and family attitudes about schizophrenia: implications for genetic counseling. Schizophr Bull. 1982; 8(3):504-13.
    View in: PubMed
    Score: 0.003
  48. Comorbid bipolar disorder and panic disorder in families with a high prevalence of bipolar disorder. Am J Psychiatry. 2002 Jan; 159(1):30-5.
    View in: PubMed
    Score: 0.003
  49. The Family Attitudes Questionnaire. Patients' and spouses' views of bipolar illness. Arch Gen Psychiatry. 1981 May; 38(5):562-8.
    View in: PubMed
    Score: 0.003
  50. Monoamine oxidase type A in fibroblasts from patients with bipolar depressive illness. Psychiatry Res. 1980 Jul; 2(3):307-14.
    View in: PubMed
    Score: 0.003
  51. A collaborative study of genetic linkage of bipolar manic-depressive illness and red/green colorblindness. A project of the biological psychiatry collaborative program of the world health organization. Acta Psychiatr Scand. 1980 Apr; 61(4):319-38.
    View in: PubMed
    Score: 0.003
  52. Plasma MAO activity unrelated to genetic vulnerability to primary affective illness. Arch Gen Psychiatry. 1977 Jun; 34(6):731-4.
    View in: PubMed
    Score: 0.003
  53. The question of X-linkage in bipolar manic-depressive illness. J Psychiatr Res. 1977; 13(2):99-117.
    View in: PubMed
    Score: 0.002
  54. Sociocultural and demographic correlates of affective disorders in Jerusalem. J Psychiatr Res. 1975 Apr; 12(1):37-50.
    View in: PubMed
    Score: 0.002
  55. Tics and Tourette's disorder: a 2- to 7-year follow-up of 54 obsessive-compulsive children. Am J Psychiatry. 1992 Sep; 149(9):1244-51.
    View in: PubMed
    Score: 0.002
  56. Hostility and depression. Psychiatry. 1968 Aug; 31(3):224-35.
    View in: PubMed
    Score: 0.001
  57. Psychiatric disorders in the relatives of probands with affective disorders. The Yale University--National Institute of Mental Health Collaborative Study. Arch Gen Psychiatry. 1984 Jan; 41(1):13-21.
    View in: PubMed
    Score: 0.001
  58. Plasma and CSF GABA in affective illness. Br J Psychiatry. 1982 Nov; 141:483-7.
    View in: PubMed
    Score: 0.001
  59. Plasma MHPG in rapid cyclers and healthy twins. Arch Gen Psychiatry. 1981 Nov; 38(11):1287-90.
    View in: PubMed
    Score: 0.001
  60. A comparison of nonpatient and bipolar patient-well spouse couples. Am J Psychiatry. 1981 Jun; 138(6):764-8.
    View in: PubMed
    Score: 0.001
  61. Human leukocyte antigen system not closely linked to or associated with bipolar manic-depressive illness. Biol Psychiatry. 1979 Aug; 14(4):615-36.
    View in: PubMed
    Score: 0.001
  62. The role of plasma amine oxidase, platelet monoamine oxidase, and red cell catechol-O-methyl transferase in severe behavioral reactions to disulfiram. Am J Psychiatry. 1979 May; 136(5):679-84.
    View in: PubMed
    Score: 0.001
  63. Reduced MAO activity in first-degree relatives of individuals with bipolar affective disorders. A preliminary report. Arch Gen Psychiatry. 1977 May; 34(5):601-6.
    View in: PubMed
    Score: 0.001
  64. Heritable factors in the severity of affective illness. Biol Psychiatry. 1976 Feb; 11(1):31-42.
    View in: PubMed
    Score: 0.001
  65. Lithium carbonate response in depression. Prediction by unipolar/bipolar illness, average-evoked response, catechol-O-methyl transferase, and family history. Arch Gen Psychiatry. 1975 Sep; 32(9):1107-11.
    View in: PubMed
    Score: 0.001
  66. Catecholamine metabolism in affective disorders. IV. Preliminary studies of norepinephrine metabolism in depressed patients treated with amitriptyline. J Psychiatr Res. 1972 Sep; 9(3):173-85.
    View in: PubMed
    Score: 0.000
  67. Psychobiological and pharmacological studies of manic-depressive illness. J Psychiatr Res. 1972 Sep; 9(3):207-26.
    View in: PubMed
    Score: 0.000
  68. Excretion of 17-OHCS in unipolar and bipolar depressed patients. Arch Gen Psychiatry. 1972 Apr; 26(4):360-3.
    View in: PubMed
    Score: 0.000
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.